Intravenous or intranasal insulin administration has improved memory function in both humans and animals (Chapman et al., 2018; Wu et al., 2023b), indicating that compromised insulin signaling pathways may be a primary defect linking AD and T2D. This evidence concerns the gene INS and Alzheimer disease.